Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes.
about
Efficacy and safety of mineralocorticoid receptor antagonists for patients with heart failure and diabetes mellitus: a systematic review and meta-analysisMineralocorticoid Receptors in the Pathophysiology of Vascular Inflammation and AtherosclerosisEndothelial mineralocorticoid receptor contributes to systolic dysfunction induced by pressure overload without modulating cardiac hypertrophy or inflammation.Mineralocorticoid receptors: an appealing target to treat coronary microvascular dysfunction in diabetes.Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activationCooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury.Spironolactone treatment attenuates vascular dysfunction in type 2 diabetic mice by decreasing oxidative stress and restoring NO/GC signalingEndothelial Mineralocorticoid Receptors Differentially Contribute to Coronary and Mesenteric Vascular Function Without Modulating Blood Pressure.Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic SubjectsAldosterone in vascular and metabolic dysfunction.Diabetes Mellitus, Microalbuminuria, and Subclinical Cardiac Disease: Identification and Monitoring of Individuals at Risk of Heart Failure.Aldosterone and the Mineralocorticoid Receptor: Risk Factors for Cardiometabolic Disorders.Targeting Select Cellular Stress Pathways to Prevent Hyperglycemia-Related Complications: Shifting the Paradigm.Therapeutic Targeting of Cellular Stress to Prevent Cardiovascular Disease: A Review of the Evidence.The endothelial mineralocorticoid receptor: mediator of the switch from vascular health to disease.Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade.Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy.The Link Between Adipose Tissue Renin-Angiotensin-Aldosterone System Signaling and Obesity-Associated Hypertension.Coronary microvascular dysfunction in diabetes mellitus.A systematic review and meta-analysis of the impact of mineralocorticoid receptor antagonists on glucose homeostasis.The Role of the Mineralocorticoid Receptor in Inflammation: Focus on Kidney and Vasculature.Relationship between cardiac microvascular dysfunction measured with 82Rubidium-PET and albuminuria in patients with diabetes mellitus.Sex-Specific Mechanisms of Resistance Vessel Endothelial Dysfunction Induced by Cardiometabolic Risk Factors.The role of spironolactone on myocardial oxidative stress in rat model of streptozotocin-induced diabetes.Plasminogen Activator Inhibitor-1 and Pericardial Fat in Individuals with Type 2 Diabetes Mellitus.Which diuretic for which hypertensive patient?
P2860
Q26773030-760BACCD-519F-4FF9-B62A-E1DCFBE5E27EQ26781416-329D1282-1FA4-47EA-870B-C8D7BD89C3E6Q33856656-3B20B2EA-FAEB-45E4-BAAE-B407491B8267Q34762502-C33307E7-7DD1-4CA3-A6B9-7319F07D567EQ35135440-442B0908-E132-4320-8A58-7389D85EC3C0Q36077685-D3B94A6A-1F92-4441-BF19-B9EF789193F2Q36121902-72104C91-702F-48A8-AC64-9813EDFD34A8Q36143316-7888B6CB-37BA-46C0-A3F7-CC353CB277F5Q36271369-2CC8B291-727B-438D-82A3-303DE11C289CQ36776435-AB50517D-606F-45BD-8DB6-A87F8183443FQ38373783-389F1650-4575-41AD-9BE0-2131CE7902DDQ38525979-5E8975F0-E287-42F2-95C2-9C62EA5C34D3Q38846534-AE18D46A-9B33-4119-BD97-73A6E353E0A4Q38990014-A8C58CAD-EBAF-48EF-A235-999BF1830752Q39032836-297E74D7-FCE6-4459-8EB8-1FBDDD01FC53Q39176512-B3DC8018-1418-478A-879E-77FE1F7ECDCBQ39190427-CCF285F0-5D48-4019-BFB8-8C29F2C1C849Q39238938-B187380F-6244-497F-9A19-4C255A32DAFEQ39393549-D7F79761-0607-4415-82B1-70D05C0EB18DQ47122991-0E536841-7022-4FE9-86A1-C4D1471AEBC9Q48025446-4C8BA09A-B8F9-4C50-A9ED-928EDE157B15Q48258379-BE3268A3-D479-4024-BEC3-9E058338E8D5Q49913747-C7F0FC68-AE31-4A9A-ADEC-F3C88F5F5CE9Q51002568-8732F89F-3325-4B98-852D-CE7FC8635822Q51266144-5DB2658F-257C-4F09-BC90-5D7B12105DA2Q54840934-A3C2D8A8-B69C-439A-8D9B-33B42862142D
P2860
Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mineralocorticoid receptor blo ...... ividuals with type 2 diabetes.
@ast
Mineralocorticoid receptor blo ...... ividuals with type 2 diabetes.
@en
Mineralocorticoid receptor blo ...... ividuals with type 2 diabetes.
@nl
type
label
Mineralocorticoid receptor blo ...... ividuals with type 2 diabetes.
@ast
Mineralocorticoid receptor blo ...... ividuals with type 2 diabetes.
@en
Mineralocorticoid receptor blo ...... ividuals with type 2 diabetes.
@nl
prefLabel
Mineralocorticoid receptor blo ...... ividuals with type 2 diabetes.
@ast
Mineralocorticoid receptor blo ...... ividuals with type 2 diabetes.
@en
Mineralocorticoid receptor blo ...... ividuals with type 2 diabetes.
@nl
P2093
P2860
P356
P1433
P1476
Mineralocorticoid receptor blo ...... ividuals with type 2 diabetes.
@en
P2093
Ajay D Rao
Courtney Foster
Gail K Adler
Marcelo F Di Carli
Maria Baimas-George
Rajesh Garg
Ravi V Shah
Raymond Y Kwong
Shelley Hurwitz
P2860
P304
P356
10.2337/DB14-0670
P407
P577
2014-08-14T00:00:00Z